Performing functional drug-response analyses in vitro using (aggressive) breast cancer cells upon treatment with the two different recombinant ITIH5 derived polypeptides, we confirmed mimicry of tumor cell growth inhibition mediated by the recombinant VIT protein only. This evidence concerns the gene ITIH5 and breast cancer.